Avishek Anant and Novartis Healthcare Pvt - Free people check

(1 - 8 from 9

)

Effectiveness of cyclosporine A in patients with moderate to ...

www.tandfonline.com

by F Marsili · · Cited by 1 — The authors would like to thank Avishek Anant and Mohammad Fahad Haroon (Novartis Healthcare Pvt. Ltd., Hyderabad, India) for editorial and ... › ... › Volume 33, Issue 1

Headline: Arial Bold 80 Text may run two lines

www.urticariaknowledgecenter.novartis.com

Avishek Anant (Novartis Healthcare Pvt. Ltd., Hyderabad), for editorial and medical writing support, which was funded by Novartis Pharma AG, Basel, ... › ...

Secukinumab Patient Demographics and Disease CorEvitas

www.corevitas.com

by B Strober — ... review and approval of the abstract. Medical writing assistance was provided by Avishek Anant PhD, Novartis Healthcare Pvt. Ltd., India. › pdf › field_attachment

Secukinumab Patient-Reported Outcomes in the Corrona ...

www.corrona.org

... review and approval of the abstract. Medical writing assistance was provided by Avishek Anant PhD, Novartis Healthcare Pvt. Ltd., India. › file › download

Secukinumab is highly efficacious and has a favourable safety ...

www.belgiandermatology.be

by A Nikkels — and Avishek Anant, PhD (Novartis Healthcare Pvt. Ltd., Hyderabad) for editorial and medical writing support, which was. › files › Nikk...

based, patient-centric management model in psoriasis

archpublichealth.biomedcentral.com

by SF Thomsen · — The authors thank Avishek Anant and Lakshmi Venkatraman, Novartis. Healthcare Pvt. Ltd., Hyderabad, India, for editorial and medical writing. by SF Thomsen · — The authors thank Avishek Anant and Lakshmi Venkatraman, Novartis Healthcare Pvt. Ltd., Hyderabad, India, for editorial and medical writing ... › pdf › articles